{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:00:32Z","timestamp":1789952432189,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    CD4\n                    <jats:sup>+<\/jats:sup>\n                    CD25\n                    <jats:sup>+<\/jats:sup>\n                    FOXP3\n                    <jats:sup>+<\/jats:sup>\n                    regulatory T cells (Treg) are highly activated in tumors and promote disease progression. Specific, universal targeting of these effector Treg cells is limited by the lack of a conserved signature across human cancers and information on their origin. Here we combine analysis of single-cell RNA-sequencing datasets with spectral flow cytometry and identify a core signature of 88 genes consistently upregulated in intratumoral Treg cells among 9 epithelial cancers. We describe 4 Treg cell subsets \u2013 CCR7\n                    <jats:sup>+<\/jats:sup>\n                    quiescent, CCR8\n                    <jats:sup>+<\/jats:sup>\n                    effector, CD161\n                    <jats:sup>+<\/jats:sup>\n                    and intermediate, with distinct tissue distribution, function, differentiation trajectories and molecular drivers. By single-cell T cell receptor sequencing, we observe that protumoral, effector CCR8\n                    <jats:sup>+<\/jats:sup>\n                    Treg cells exhibit little clonal relationship with other Treg cell subsets inside tumors, but are clonally related to Treg cells in tumor-draining lymph nodes, as well as conventional T cells in tumors. This resource provides insights for development and fine-tuning of CCR8\n                    <jats:sup>+<\/jats:sup>\n                    Treg cell-targeting therapies in cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76670-6","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T08:04:35Z","timestamp":1787299475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular heterogeneity and clonal origin of CCR8+ effector regulatory T cells in human cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-2808","authenticated-orcid":false,"given":"Julian","family":"Swatler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-4365","authenticated-orcid":false,"given":"Simone","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Voulaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Marulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Sambanthamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Scamardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Feno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Camisaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Losurdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-3640","authenticated-orcid":false,"given":"Emilia Maria Cristina","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-7678","authenticated-orcid":false,"given":"Enrico","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"76670_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.immuni.2021.03.007","volume":"54","author":"M Delacher","year":"2021","unstructured":"Delacher, M. et al. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. Immunity 54, 702\u2013720.e717 (2021).","journal-title":"Immunity"},{"key":"76670_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","volume":"21","author":"AR Munoz-Rojas","year":"2021","unstructured":"Munoz-Rojas, A. R. & Mathis, D. Tissue regulatory T cells: regulatory chameleons. Nat. Rev. Immunol. 21, 597\u2013611 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"76670_CR3","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1084\/jem.20130762","volume":"210","author":"PD Bos","year":"2013","unstructured":"Bos, P. D., Plitas, G., Rudra, D., Lee, S. Y. & Rudensky, A. Y. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J. Exp. Med. 210, 2435\u20132466 (2013).","journal-title":"J. Exp. Med."},{"key":"76670_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1158\/2326-6066.CIR-23-0517","volume":"12","author":"J Swatler","year":"2024","unstructured":"Swatler, J. et al. CD4+ Regulatory T cells in human cancer: subsets, origin, and molecular regulation. Cancer Immunol. Res. 12, 393\u2013399 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"76670_CR5","doi-asserted-by":"crossref","unstructured":"Van Damme, H. et al. Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy. J. Immunother. Cancer 9, e001749 (2021).","DOI":"10.1136\/jitc-2020-001749"},{"key":"76670_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2250","volume":"7","author":"MP Colombo","year":"2007","unstructured":"Colombo, M. P. & Piconese, S. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat. Rev. Cancer 7, 880\u2013887 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"76670_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","volume":"45","author":"G Plitas","year":"2016","unstructured":"Plitas, G. et al. Regulatory T cells exhibit distinct features in human breast cancer. Immunity 45, 1122\u20131134 (2016).","journal-title":"Immunity"},{"key":"76670_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26091-4","volume":"12","author":"MC Kim","year":"2021","unstructured":"Kim, M. C. et al. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat. Commun. 12, 5764 (2021).","journal-title":"Nat. Commun."},{"key":"76670_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf8495","volume":"13","author":"CA Chuckran","year":"2021","unstructured":"Chuckran, C. A. et al. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. Sci. Transl. Med. 13, eabf8495 (2021).","journal-title":"Sci. Transl. Med."},{"key":"76670_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","volume":"45","author":"M De Simone","year":"2016","unstructured":"De Simone, M. et al. Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells. Immunity 45, 1135\u20131147 (2016).","journal-title":"Immunity"},{"key":"76670_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04718-w","volume":"605","author":"F Mair","year":"2022","unstructured":"Mair, F. et al. Extricating human tumour immune alterations from tissue inflammation. Nature 605, 728\u2013735 (2022).","journal-title":"Nature"},{"key":"76670_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","volume":"21","author":"S Kumagai","year":"2024","unstructured":"Kumagai, S., Itahashi, K. & Nishikawa, H. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat. Rev. Clin. Oncol. 21, 337\u2013353 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76670_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay, C., Tanaka, A. & Sakaguchi, S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 41, 450\u2013465 (2023).","journal-title":"Cancer Cell"},{"key":"76670_CR14","doi-asserted-by":"crossref","unstructured":"Galluzzi, L., Smith, K. N., Liston, A. & Garg, A. D. The diversity of CD8(+) T cell dysfunction in cancer and viral infection. Nat. Rev. Immunol. 25, 662\u2013679 (2025).","DOI":"10.1038\/s41577-025-01161-6"},{"key":"76670_CR15","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi, G. et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J. Clin. Invest. 130, 3137\u20133150 (2020).","journal-title":"J. Clin. Invest."},{"key":"76670_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"76670_CR17","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","volume":"188","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell 188, 3081\u20133096.e3019 (2025).","journal-title":"Cell"},{"key":"76670_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk0957","volume":"7","author":"K Itahashi","year":"2022","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol. 7, eabk0957 (2022).","journal-title":"Sci. Immunol."},{"key":"76670_CR19","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","volume":"77","author":"G Alvisi","year":"2022","unstructured":"Alvisi, G. et al. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. J. Hepatol. 77, 1359\u20131372 (2022).","journal-title":"J. Hepatol."},{"key":"76670_CR20","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cell.2017.08.004","volume":"170","author":"Y Grinberg-Bleyer","year":"2017","unstructured":"Grinberg-Bleyer, Y. et al. NF-kappaB c-Rel is crucial for the regulatory T cell immune checkpoint in cancer. Cell 170, 1096\u20131108 e1013 (2017).","journal-title":"Cell"},{"key":"76670_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg1487","volume":"8","author":"AG Dykema","year":"2023","unstructured":"Dykema, A. G. et al. Lung tumor-infiltrating T(reg) have divergent transcriptional profiles and function linked to checkpoint blockade response. Sci. Immunol. 8, eadg1487 (2023).","journal-title":"Sci. Immunol."},{"key":"76670_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ccell.2024.05.013","volume":"42","author":"SN Geels","year":"2024","unstructured":"Geels, S. N. et al. Interruption of the intratumor CD8(+) T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell 42, 1051\u20131066 e1057 (2024).","journal-title":"Cancer Cell"},{"key":"76670_CR23","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1158\/2159-8290.CD-22-0851","volume":"13","author":"AM van der Leun","year":"2023","unstructured":"van der Leun, A. M. et al. Dual immune checkpoint blockade induces analogous alterations in the dysfunctional CD8+ T-cell and activated treg compartment. Cancer Discov. 13, 2212\u20132227 (2023).","journal-title":"Cancer Discov."},{"key":"76670_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo5558","volume":"8","author":"SK Whiteside","year":"2023","unstructured":"Whiteside, S. K. et al. Acquisition of suppressive function by conventional T cells limits antitumor immunity upon T(reg) depletion. Sci. Immunol. 8, eabo5558 (2023).","journal-title":"Sci. Immunol."},{"key":"76670_CR25","doi-asserted-by":"crossref","unstructured":"Ahmadzadeh, M. et al. Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Sci. Immunol. 4, eaao4310 (2019).","DOI":"10.1126\/sciimmunol.aao4310"},{"key":"76670_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21297-y","volume":"12","author":"M Xydia","year":"2021","unstructured":"Xydia, M. et al. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients. Nat. Commun. 12, 1119 (2021).","journal-title":"Nat. Commun."},{"key":"76670_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17046-2","volume":"11","author":"NG Nunez","year":"2020","unstructured":"Nunez, N. G. et al. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nat. Commun. 11, 3272 (2020).","journal-title":"Nat. Commun."},{"key":"76670_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41590-019-0429-7","volume":"20","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Connecting blood and intratumoral T(reg) cell activity in predicting future relapse in breast cancer. Nat. Immunol. 20, 1220\u20131230 (2019).","journal-title":"Nat. Immunol."},{"key":"76670_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"76670_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15851-3","volume":"11","author":"X Li","year":"2020","unstructured":"Li, X. et al. Deep learning enables accurate clustering with batch effect removal in single-cell RNA-seq analysis. Nat. Commun. 11, 2338 (2020).","journal-title":"Nat. Commun."},{"key":"76670_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41590-022-01395-9","volume":"24","author":"MML Poon","year":"2023","unstructured":"Poon, M. M. L. et al. Tissue adaptation and clonal segregation of human memory T cells in barrier sites. Nat. Immunol. 24, 309\u2013319 (2023).","journal-title":"Nat. Immunol."},{"key":"76670_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4896","volume":"376","author":"C Tabula Sapiens","year":"2022","unstructured":"Tabula Sapiens, C. et al. The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Science 376, eabl4896 (2022).","journal-title":"Science"},{"key":"76670_CR33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41591-024-02895-x","volume":"30","author":"MF Thomas","year":"2024","unstructured":"Thomas, M. F. et al. Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nat. Med. 30, 1349\u20131362 (2024).","journal-title":"Nat. Med."},{"key":"76670_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"76670_CR35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.ajpath.2011.11.032","volume":"180","author":"G Parsonage","year":"2012","unstructured":"Parsonage, G. et al. CXCR6 and CCR5 localize T lymphocyte subsets in nasopharyngeal carcinoma. Am. J. Pathol. 180, 1215\u20131222 (2012).","journal-title":"Am. J. Pathol."},{"key":"76670_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47981-3","volume":"15","author":"E Bonnin","year":"2024","unstructured":"Bonnin, E. et al. CD74 supports accumulation and function of regulatory T cells in tumors. Nat. Commun. 15, 3749 (2024).","journal-title":"Nat. Commun."},{"key":"76670_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","volume":"19","author":"M Dominguez-Villar","year":"2018","unstructured":"Dominguez-Villar, M. & Hafler, D. A. Regulatory T cells in autoimmune disease. Nat. Immunol. 19, 665\u2013673 (2018).","journal-title":"Nat. Immunol."},{"key":"76670_CR38","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-025-00832-9","volume":"25","author":"CJ Imianowski","year":"2025","unstructured":"Imianowski, C. J., Chen, Q., Workman, C. J. & Vignali, D. A. A. Regulatory T cells in the tumour microenvironment. Nat. Rev. Cancer 25, 703\u2013722 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"76670_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"76670_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09670-4","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM. Nat. Commun. 10, 1903 (2019).","journal-title":"Nat. Commun."},{"key":"76670_CR41","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"76670_CR42","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin, A. et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25, 1282\u20131293.e1287 (2017).","journal-title":"Cell Metab."},{"key":"76670_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40790-0","volume":"14","author":"S Puccio","year":"2023","unstructured":"Puccio, S. et al. CRUSTY: a versatile web platform for the rapid analysis and visualization of high-dimensional flow cytometry data. Nat. Commun. 14, 5102 (2023).","journal-title":"Nat. Commun."},{"key":"76670_CR44","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"76670_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41592-021-01142-2","volume":"18","author":"L Song","year":"2021","unstructured":"Song, L. et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data. Nat. Methods 18, 627\u2013630 (2021).","journal-title":"Nat. Methods"},{"key":"76670_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.732530","volume":"12","author":"S Dehmani","year":"2021","unstructured":"Dehmani, S. et al. SIRPgamma-CD47 interaction positively regulates the activation of human T cells in situation of chronic stimulation. Front. Immunol. 12, 732530 (2021).","journal-title":"Front. Immunol."},{"key":"76670_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41590-018-0290-0","volume":"20","author":"WC Cheng","year":"2019","unstructured":"Cheng, W. C. et al. Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle. Nat. Immunol. 20, 206\u2013217 (2019).","journal-title":"Nat. Immunol."},{"key":"76670_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2497171","volume":"14","author":"R Wang","year":"2025","unstructured":"Wang, R. et al. TNFR2\/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8(+) T cell function. Oncoimmunology 14, 2497171 (2025).","journal-title":"Oncoimmunology"},{"key":"76670_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"76670_CR50","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker, A. M. et al. CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines. Blood 121, 2647\u20132658 (2013).","journal-title":"Blood"},{"key":"76670_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","volume":"21","author":"A Hatzioannou","year":"2020","unstructured":"Hatzioannou, A. et al. An intrinsic role of IL-33 in T(reg) cell-mediated tumor immunoevasion. Nat. Immunol. 21, 75\u201385 (2020).","journal-title":"Nat. Immunol."},{"key":"76670_CR52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1158\/2326-6066.CIR-18-0066","volume":"6","author":"AE Overacre-Delgoffe","year":"2018","unstructured":"Overacre-Delgoffe, A. E. & Vignali, D. A. A. Treg fragility: a prerequisite for effective antitumor immunity?. Cancer Immunol. Res. 6, 882\u2013887 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"76670_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito, T. et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat. Med. 22, 679\u2013684 (2016).","journal-title":"Nat. Med."},{"key":"76670_CR54","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.immuni.2026.03.011","volume":"59","author":"VI Maltez","year":"2026","unstructured":"Maltez, V. I. et al. Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment. Immunity 59, 1058\u20131074.e1057 (2026).","journal-title":"Immunity"},{"key":"76670_CR55","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","volume":"169","author":"AE Overacre-Delgoffe","year":"2017","unstructured":"Overacre-Delgoffe, A. E. et al. Interferon-gamma drives T(reg) fragility to promote anti-tumor immunity. Cell 169, 1130\u20131141.e1111 (2017).","journal-title":"Cell"},{"key":"76670_CR56","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-021-03326-4","volume":"591","author":"R Zappasodi","year":"2021","unstructured":"Zappasodi, R. et al. CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours. Nature 591, 652\u2013658 (2021).","journal-title":"Nature"},{"key":"76670_CR57","doi-asserted-by":"crossref","unstructured":"Karaki, S. et al. CXCR6 deficiency impairs cancer vaccine efficacy and CD8(+) resident memory T-cell recruitment in head and neck and lung tumors. J Immunother. Cancer 9, e001948 (2021).","DOI":"10.1136\/jitc-2020-001948"},{"key":"76670_CR58","doi-asserted-by":"publisher","unstructured":"Tosello Boari J. et al. Common origin for effector and regulatory follicular and tissue-adapted CD4+ T cells in non-small cell lung cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.09.17.674622 (2025).","DOI":"10.1101\/2025.09.17.674622"},{"key":"76670_CR59","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ni.3004","volume":"15","author":"AG Levine","year":"2014","unstructured":"Levine, A. G., Arvey, A., Jin, W. & Rudensky, A. Y. Continuous requirement for the TCR in regulatory T cell function. Nat. Immunol. 15, 1070\u20131078 (2014).","journal-title":"Nat. Immunol."},{"key":"76670_CR60","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-022-04682-5","volume":"605","author":"G Oliveira","year":"2022","unstructured":"Oliveira, G. et al. Landscape of helper and regulatory antitumour CD4(+) T cells in melanoma. Nature 605, 532\u2013538 (2022).","journal-title":"Nature"},{"key":"76670_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08076-7","volume":"636","author":"MA Cardenas","year":"2024","unstructured":"Cardenas, M. A. et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature 636, 224\u2013232 (2024).","journal-title":"Nature"},{"key":"76670_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska, N. et al. CD8(+) T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity 56, 107\u2013124 e105 (2023).","journal-title":"Immunity"},{"key":"76670_CR63","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim, M. K. et al. Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 186, 1127\u20131143 e1118 (2023).","journal-title":"Cell"},{"key":"76670_CR64","doi-asserted-by":"crossref","unstructured":"Gong, J. et al. Efficacy and safety of cafelkibart (LM-108), an anti-CCR8 monoclonal antibody, in combination with anti-PD-1 therapy in patients with pancreatic cancer: results from phase 1\/2 studies. J. Clin. Oncol. 42, 4010 (2025).","DOI":"10.1200\/JCO.2025.43.16_suppl.4010"},{"key":"76670_CR65","doi-asserted-by":"crossref","unstructured":"Patnaik, A. et al. Preliminary results of a phase 1, first-in-human, dose escalation study of the anti-CCR8 cytolytic antibody, CHS-114 (formerly SRF114) in patients with advanced solid tumors. J. Clin. Oncol. 42, 2664 (2024).","DOI":"10.1200\/JCO.2024.42.16_suppl.2664"},{"key":"76670_CR66","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4049\/jimmunol.1901006","volume":"204","author":"A Ko","year":"2020","unstructured":"Ko, A. et al. TCR repertoires of thymic conventional and regulatory T cells: identification and characterization of both unique and shared TCR sequences. J. Immunol. 204, 858\u2013867 (2020).","journal-title":"J. Immunol."},{"key":"76670_CR67","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med. 377, 2500\u20132501 (2017).","journal-title":"N. Engl. J. Med."},{"key":"76670_CR68","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"76670_CR69","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s42003-021-02595-z","volume":"4","author":"A Losurdo","year":"2021","unstructured":"Losurdo, A. et al. Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer. Commun. Biol. 4, 1117 (2021).","journal-title":"Commun. Biol."},{"key":"76670_CR70","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/s41596-019-0166-2","volume":"14","author":"J Brummelman","year":"2019","unstructured":"Brummelman, J. et al. Development, application and computational analysis of high-dimensional fluorescent antibody panels for single-cell flow cytometry. Nat. Protoc. 14, 1946\u20131969 (2019).","journal-title":"Nat. Protoc."},{"key":"76670_CR71","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.202170126","volume":"51","author":"A Cossarizza","year":"2021","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur. J. Immunol. 51, 2708\u20133145 (2021).","journal-title":"Eur. J. Immunol."},{"key":"76670_CR72","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636\u2013645 (2015).","journal-title":"Cytom. A"},{"key":"76670_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-driven phenotypic dissection of aml reveals progenitor-like cells that correlate with prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"76670_CR74","unstructured":"Borcherding, N. utility: collection of tumor-infiltrating lymphocyte single-cell experiments with TCR (v0.0.4). Zenodo (2022)."},{"key":"76670_CR75","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308 e1236 (2018).","journal-title":"Cell"},{"key":"76670_CR76","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","volume":"4","author":"N Borcherding","year":"2021","unstructured":"Borcherding, N. et al. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics. Commun. Biol. 4, 122 (2021).","journal-title":"Commun. Biol."},{"key":"76670_CR77","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","volume":"39","author":"C Krishna","year":"2021","unstructured":"Krishna, C. et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell 39, 662\u2013677.e666 (2021).","journal-title":"Cancer Cell"},{"key":"76670_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20019-0","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat. Commun. 11, 6268 (2020).","journal-title":"Nat. Commun."},{"key":"76670_CR79","doi-asserted-by":"crossref","unstructured":"Gueguen, P. et al. Contribution of resident and circulating precursors to tumor-infiltrating CD8(+) T cell populations in lung cancer. Sci. Immunol. 6, eabd5778 (2021).","DOI":"10.1126\/sciimmunol.abd5778"},{"key":"76670_CR80","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","volume":"579","author":"TD Wu","year":"2020","unstructured":"Wu, T. D. et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature 579, 274\u2013278 (2020).","journal-title":"Nature"},{"key":"76670_CR81","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ccell.2022.02.013","volume":"40","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Immune phenotypic linkage between colorectal cancer and liver metastasis. Cancer Cell 40, 424\u2013437.e425 (2022).","journal-title":"Cancer Cell"},{"key":"76670_CR82","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2159-8290.CD-22-0686","volume":"13","author":"RD Chow","year":"2023","unstructured":"Chow, R. D. et al. Distinct mechanisms of mismatch-repair deficiency delineate two modes of response to anti-PD-1 immunotherapy in endometrial carcinoma. Cancer Discov. 13, 312\u2013331 (2023).","journal-title":"Cancer Discov."},{"key":"76670_CR83","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845 e820 (2019).","journal-title":"Cell"},{"key":"76670_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"76670_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl5197","volume":"376","author":"C Dominguez Conde","year":"2022","unstructured":"Dominguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, eabl5197 (2022).","journal-title":"Science"},{"key":"76670_CR86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"76670_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50194-3","volume":"15","author":"Z Zeng","year":"2024","unstructured":"Zeng, Z. et al. OmicVerse: a framework for bridging and deepening insights across bulk and single-cell sequencing. Nat. Commun. 15, 5983 (2024).","journal-title":"Nat. Commun."},{"key":"76670_CR88","doi-asserted-by":"publisher","first-page":"W207","DOI":"10.1093\/nar\/gkad347","volume":"51","author":"L Kolberg","year":"2023","unstructured":"Kolberg, L. et al. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update). Nucleic Acids Res. 51, W207\u2013W212 (2023).","journal-title":"Nucleic Acids Res."},{"key":"76670_CR89","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1093\/bioinformatics\/btaa611","volume":"36","author":"G Sturm","year":"2020","unstructured":"Sturm, G. et al. Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data. Bioinformatics 36, 4817\u20134818 (2020).","journal-title":"Bioinformatics"},{"key":"76670_CR90","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: visualization of intersecting sets. IEEE Trans. Vis. Comput. Graph 20, 1983\u20131992 (2014).","journal-title":"IEEE Trans. Vis. Comput. Graph"},{"key":"76670_CR91","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1158\/2326-6066.CIR-22-0403","volume":"10","author":"Y Liu","year":"2022","unstructured":"Liu, Y. & Han, L. TRUST4 interrogates the immune receptor repertoire in oncology and immunotherapy. Cancer Immunol. Res. 10, 786 (2022).","journal-title":"Cancer Immunol. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76670-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76670-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:03:05Z","timestamp":1789948985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76670-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76670"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76670-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.L. reports consulting fees from Swarm Oncology, Pfizer, Biolegend, Amgen, and Menarini, unrelated to this work, and advisory board engagement from Gilead. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9994"}}